Seres Therapeutics, Inc.·4

Feb 8, 9:35 PM ET

Cloghessy Paula 4

4 · Seres Therapeutics, Inc. · Filed Feb 8, 2022

Insider Transaction Report

Form 4
Period: 2022-02-07
Cloghessy Paula
See Remarks
Transactions
  • Award

    Stock Options (right to buy)

    2022-02-07+190,000190,000 total
    Exercise: $7.60Exp: 2032-02-06Common Stock (190,000 underlying)
Footnotes (1)
  • [F1]This option will vest and become exercisable as to 25% of the shares on February 7, 2023. The remainder of the shares will vest and become exercisable in 12 equal quarterly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION